Catalyst Pharmaceuticals' IPO

Catalyst Pharmaceuticals raised a round of funding on November 18, 2006. Investors include Public.

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. Cataly…

Articles about Catalyst Pharmaceuticals' IPO: